Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.

The company behind the weight loss sensation that transformed bodies and bank accounts across America just showed its own CEO ...

Lars Fruergaard Jørgensen will step down after eight years helming the Danish drugmaker, shares of which have lost more than half their value over the past 12 months.

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to ...

Outfit? Check. Glassy skin? Check. Glam life as a bridal stylist with a quarter of a million TikTok followers? Check. In so ...

Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes ...

Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the company's board of directors, citing ...

Among patients with diabetes who underwent PCI after an acute heart attack, those taking a GLP-1 had better survival rates ...

If you’ve been on TikTok or any other social media — or any kind of media, for that matter — you’ve probably come across ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Novo Nordisk's CEO, who led its boom driven by obesity and diabetes medications only to see that success stall, is stepping ...